Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
A subset of patients with COVID-19 develops a hyperinflammatory syndrome that has similarities with other hyperinflammatory disorders. We developed a six-criterion additive scale for the development of cHIs. The cHIS scale might be helpful in defining target populations for trials and immunomodulatory therapies.

Related Post